PREMIER HEALTH OF AMERICA IN (PHA.CA) Stock Fundamental Analysis

TSX-V:PHA • CA74052G1063

0.02 CAD
0 (0%)
Last: Feb 20, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

PHA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 13 industry peers in the Health Care Providers & Services industry. Both the profitability and financial health of PHA have multiple concerns. PHA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year PHA has reported negative net income.
  • PHA had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: PHA reported negative net income in multiple years.
  • Of the past 5 years PHA 4 years had a positive operating cash flow.
PHA.CA Yearly Net Income VS EBIT VS OCF VS FCFPHA.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -20.74%, PHA is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
ROA -20.74%
ROE N/A
ROIC N/A
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
PHA.CA Yearly ROA, ROE, ROICPHA.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -100 -200 -300

1.3 Margins

  • The Gross Margin of PHA (16.12%) is worse than 71.43% of its industry peers.
  • In the last couple of years the Gross Margin of PHA has declined.
  • The Profit Margin and Operating Margin are not available for PHA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.12%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
PHA.CA Yearly Profit, Operating, Gross MarginsPHA.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • PHA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, PHA has more shares outstanding
  • The number of shares outstanding for PHA has been increased compared to 5 years ago.
  • PHA has a worse debt/assets ratio than last year.
PHA.CA Yearly Shares OutstandingPHA.CA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
PHA.CA Yearly Total Debt VS Total AssetsPHA.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 0.53, we must say that PHA is in the distress zone and has some risk of bankruptcy.
  • PHA has a worse Altman-Z score (0.53) than 71.43% of its industry peers.
  • The Debt to FCF ratio of PHA is 5.80, which is a neutral value as it means it would take PHA, 5.80 years of fcf income to pay off all of its debts.
  • PHA's Debt to FCF ratio of 5.80 is fine compared to the rest of the industry. PHA outperforms 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.8
Altman-Z 0.53
ROIC/WACCN/A
WACC9.85%
PHA.CA Yearly LT Debt VS Equity VS FCFPHA.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

  • PHA has a Current Ratio of 0.44. This is a bad value and indicates that PHA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of PHA (0.44) is worse than 64.29% of its industry peers.
  • PHA has a Quick Ratio of 0.44. This is a bad value and indicates that PHA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • PHA has a Quick ratio of 0.44. This is in the lower half of the industry: PHA underperforms 64.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
PHA.CA Yearly Current Assets VS Current LiabilitesPHA.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • PHA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 7.76%.
  • PHA shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.61%.
  • Measured over the past years, PHA shows a very strong growth in Revenue. The Revenue has been growing by 68.58% on average per year.
EPS 1Y (TTM)7.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.24%
Revenue 1Y (TTM)-22.61%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%-47.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.79% on average over the next years. This is quite good.
  • PHA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.61% yearly.
EPS Next Y40.21%
EPS Next 2Y18.19%
EPS Next 3Y11.79%
EPS Next 5YN/A
Revenue Next Year-20.72%
Revenue Next 2Y-10.85%
Revenue Next 3Y-5.61%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PHA.CA Yearly Revenue VS EstimatesPHA.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
PHA.CA Yearly EPS VS EstimatesPHA.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 -0.1 -0.15

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • PHA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year PHA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PHA.CA Price Earnings VS Forward Price EarningsPHA.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

  • PHA's Enterprise Value to EBITDA is on the same level as the industry average.
  • 100.00% of the companies in the same industry are more expensive than PHA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.14
EV/EBITDA 197.13
PHA.CA Per share dataPHA.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5 2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.19%
EPS Next 3Y11.79%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for PHA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

PREMIER HEALTH OF AMERICA IN

TSX-V:PHA (2/20/2026, 7:00:00 PM)

0.02

0 (0%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)12-18
Earnings (Next)02-25
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners42.81%
Ins Owner ChangeN/A
Market Cap1.11M
Revenue(TTM)114.64M
Net Income(TTM)-11.21M
Analysts40
Price Target0.2 (900%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-46.08%
Min Revenue beat(2)-52.2%
Max Revenue beat(2)-39.96%
Revenue beat(4)0
Avg Revenue beat(4)-35.99%
Min Revenue beat(4)-52.2%
Max Revenue beat(4)-23.88%
Revenue beat(8)1
Avg Revenue beat(8)-19.64%
Revenue beat(12)2
Avg Revenue beat(12)-14.13%
Revenue beat(16)5
Avg Revenue beat(16)-4.15%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF 0.14
P/OCF 0.11
P/B N/A
P/tB N/A
EV/EBITDA 197.13
EPS(TTM)-0.2
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)0.14
FCFY701.85%
OCF(TTM)0.19
OCFY935.33%
SpS2.07
BVpS-0.09
TBVpS-0.63
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.74%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.12%
FCFM 6.8%
ROA(3y)-6.71%
ROA(5y)-3.2%
ROE(3y)-105.76%
ROE(5y)-61.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.25%
GM growth 5Y-4.32%
F-Score4
Asset Turnover2.12
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 5.8
Debt/EBITDA 4.38
Cap/Depr 33.89%
Cap/Sales 2.26%
Interest Coverage N/A
Cash Conversion 4534.5%
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z 0.53
F-Score4
WACC9.85%
ROIC/WACCN/A
Cap/Depr(3y)35.11%
Cap/Depr(5y)76.64%
Cap/Sales(3y)1.6%
Cap/Sales(5y)1.86%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.24%
EPS Next Y40.21%
EPS Next 2Y18.19%
EPS Next 3Y11.79%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.61%
Revenue growth 3Y33.41%
Revenue growth 5Y68.58%
Sales Q2Q%-47.18%
Revenue Next Year-20.72%
Revenue Next 2Y-10.85%
Revenue Next 3Y-5.61%
Revenue Next 5YN/A
EBIT growth 1Y-862.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-41.28%
EBIT Next 3Y-11.94%
EBIT Next 5YN/A
FCF growth 1Y238.34%
FCF growth 3Y400.47%
FCF growth 5Y56.2%
OCF growth 1Y360.3%
OCF growth 3Y44.26%
OCF growth 5Y70.26%

PREMIER HEALTH OF AMERICA IN / PHA.CA FAQ

What is the fundamental rating for PHA stock?

ChartMill assigns a fundamental rating of 2 / 10 to PHA.CA.


What is the valuation status of PREMIER HEALTH OF AMERICA IN (PHA.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to PREMIER HEALTH OF AMERICA IN (PHA.CA). This can be considered as Overvalued.


How profitable is PREMIER HEALTH OF AMERICA IN (PHA.CA) stock?

PREMIER HEALTH OF AMERICA IN (PHA.CA) has a profitability rating of 1 / 10.